BRAF/MEK inhibitor rechallenge in advanced melanoma patients. Van Not OJ, van den Eertwegh AJM, Haanen JB, van Rijn RS, et al. Cancer 2024 Jan 10. doi: 10.1002/cncr.35178.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Van Not OJ, van den Eertwegh AJM, Haanen JB, van Rijn RS, et al. BRAF/MEK inhibitor rechallenge in advanced melanoma patients. Cancer 2024 Jan 10. doi: 10.1002/cncr.35178.
PMID: 38198485